0001171843-20-001364.txt : 20200227
0001171843-20-001364.hdr.sgml : 20200227
20200227185444
ACCESSION NUMBER: 0001171843-20-001364
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200225
FILED AS OF DATE: 20200227
DATE AS OF CHANGE: 20200227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAND RAYMOND J
CENTRAL INDEX KEY: 0001225613
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14027
FILM NUMBER: 20664688
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anika Therapeutics, Inc.
CENTRAL INDEX KEY: 0000898437
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043145961
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: (781) 457-9000
MAIL ADDRESS:
STREET 1: 32 WIGGINS AVENUE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA THERAPEUTICS INC
DATE OF NAME CHANGE: 19970114
FORMER COMPANY:
FORMER CONFORMED NAME: ANIKA RESEARCH INC
DATE OF NAME CHANGE: 19930309
4
1
ownership.xml
X0306
4
2020-02-25
0
0000898437
Anika Therapeutics, Inc.
ANIK
0001225613
LAND RAYMOND J
32 WIGGINS AVENUE
BEDFORD
MA
01730
1
0
0
0
Common Stock
2020-02-25
4
A
0
4107
0
A
16099
D
Common Stock
2020-02-26
4
S
0
2700
42.68
D
13399
D
These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 25, 2021.
On February 26, 2020, Mr. Land sold 2,700 shares in multiple trades ranging from $42.53 to $42.80. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.
/s/ Raymond J. Land
2020-02-27